儿童连续性肾脏替代治疗中的抗菌药物剂量推荐:当前证据的批判性评价
本研究基于PHIS数据库2018年7月1日至2021年6月30日20家医院812例次住院,识别出77种抗菌药物在CRRT当日计费,其中15种在≥10%的住院中与CRRT同日使用,作者另选4种临床重要药物。对19种药物检索儿童PK研究,仅8种(42.1%)有剂量推荐;Lexi-Comp对17种(89.5%)提供CRRT特异性剂量指导,但仅1种直接基于儿童CRRT研究。8种有PK数据的药物中,Lexi-Comp与原始文献完全一致3种(37.5%)、部分一致3种(37.5%)、不一致2种(25%)。作者认为儿童CRRT抗菌药物剂量推荐存在显著数据缺口。
要点
- 20家PHIS医院812例次住院中,77种抗菌药物在CRRT当日计费,15种在≥10%的住院中与CRRT同日使用。
- 19种目标药物仅8种(42.1%)有儿童PK研究并给出剂量推荐。
- Lexi-Comp对17种(89.5%)提供CRRT特异性剂量指导,但仅1种直接基于儿童CRRT研究。
- 8种有PK数据的药物中,Lexi-Comp与原始文献完全一致3种(37.5%)、部分一致3种(37.5%)、不一致2种(25%)。
适用人群与场景
- 2018年7月1日至2021年6月30日期间在20家PHIS医院住院、接受CRRT且当日计费抗菌药物的危重儿童。
- 药物入选条件:在≥10%的住院中于至少一个CRRT日使用;作者另选4种临床重要抗菌药物。
研究设计与关键结果
- 研究类型:基于PHIS数据库的回顾性分析加文献系统检索与剂量推荐一致性评价。
- 样本量:812例次住院,来自20家PHIS医院;识别出77种独特抗菌药物。
- 15种抗菌药物在≥10%的住院中与CRRT同日计费,作者另选4种临床重要药物,共19种目标药物。
- 19种药物中检索到20项儿童PK研究,仅8种(42.1%)研究包含剂量推荐。
- Lexi-Comp对17种(89.5%)提供某种CRRT特异性剂量指导,其中仅1种直接基于儿童CRRT研究。
- 8种有PK数据的药物中,Lexi-Comp与原始文献剂量推荐完全一致3种(37.5%),不一致2种(25%),部分一致3种(37.5%,原始文献给出多种方案且Lexi-Comp推荐其中至少一种)。
证据类型、等级与局限
- 证据类型:基于数据库的回顾性分析加文献检索与剂量参考数据库比较研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为儿童CRRT抗菌药物剂量推荐存在显著数据缺口,未来研究应聚焦儿童CRRT抗菌药物剂量,提供可靠数据以便剂量推荐及时纳入三级剂量参考数据库。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Continuous renal replacement therapy (CRRT) is commonly employed in critically ill children and is known to affect antimicrobial pharmacokinetics. There is a lack of readily available, evidence-based antimicrobial dosing recommendations in pediatric CRRT. This study aims to quantify commonly used antimicrobial drugs in pediatric CRRT and identify gaps between contemporary literature-based dosing recommendations and those presented in a frequently used dosing reference.
METHODS: The Pediatric Health Information System (PHIS) database was queried from July 1, 2018 through June 30, 2021 to identify admissions in which antimicrobials were billed on the same day as CRRT. Drugs of interest were selected if at least 10% of admission involved administration on at least one CRRT day, with additional clinically important antimicrobials selected by the authors. A comprehensive literature search was performed to identify antimicrobial pharmacokinetic (PK) studies in children for each selected drug. For identified articles, dosing recommendations were extracted and compared to those in a popular tertiary dosing reference (Lexi-Comp Online database). The level of agreement of the dosing recommendations was assessed.
RESULTS: 77 unique antimicrobial agents were identified amongst 812 admissions from 20 different PHIS hospitals. Fifteen antimicrobials were billed on the same day as CRRT in ≥10% of admissions, with 4 additional drugs deemed clinically relevant by the authors. Twenty PK studies were identified for these 19 drugs, and dosing recommendations were included in 8 (42.1%) of them. Seventeen agents (89.5%) had some type of CRRT-specific dosing guidance in Lexi-Comp, with only 1 directly based on a pediatric CRRT study. For the 8 agents with PK data available, Lexi-Comp recommendations matched primary literature dosing guidance in 3 (37.5%). Two (25%) lacked agreement between the Lexi-Comp and primary literature, and the remaining 3 (37.5%) had partial agreement with multiple dosing regimens suggested in the primary literature and at least one of these regimens recommended by Lexi-Comp.
CONCLUSION: Significant gaps exist in the data supporting antimicrobial dosing recommendations for children receiving CRRT. Future studies should focus on antimicrobial dosing in pediatric CRRT, emphasizing provision of robust data from which dosing recommendations can be promptly incorporated into tertiary dosing references.
参考来源
- Stitt G, Dubinsky S, Edginton A, et al. Antimicrobial Dosing Recommendations in Pediatric Continuous Renal Replacement Therapy: A Critical Appraisal of Current Evidence. Front Pediatr. 2022. PMID: 35633961. doi:10.3389/fped.2022.889958
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。